Loading…

CJ CheilJedang and Daesang reported weak third-quarter 2023 bio-business results, with CJ's bio sales down 17% and operating profit down 90%, linked to poor lysine markets in the first half. Lysine prices are expected to rebound in the second half as Chinese pig-sector support policies lift demand.
A lysine price rebound driven by recovering Chinese hog demand supports firmer amino acid prices for feed formulators, while soybean-related product weakness weighed on margins.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.